BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17585187)

  • 1. [Role of liver biopsy in the assessment of hepatic fibrosis--its utility and limitations].
    Jin SY
    Korean J Hepatol; 2007 Jun; 13(2):138-45. PubMed ID: 17585187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of fibrosis and cirrhosis in liver biopsies: an update.
    Germani G; Hytiroglou P; Fotiadu A; Burroughs AK; Dhillon AP
    Semin Liver Dis; 2011 Feb; 31(1):82-90. PubMed ID: 21344353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of hepatic injury in patients with chronic viral hepatitis].
    Hrstić I; Ostojić R; Vucelić B
    Acta Med Croatica; 2009 Dec; 63(5):371-5. PubMed ID: 20198894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of liver fibrosis.
    Di Sario A; Feliciangeli G; Bendia E; Benedetti A
    Eur Rev Med Pharmacol Sci; 2004; 8(1):11-8. PubMed ID: 15209150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?
    Sebastiani G; Alberti A
    J Viral Hepat; 2012 Jan; 19 Suppl 1():18-32. PubMed ID: 22233410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of fibrosis in chronic liver diseases.
    Zhou K; Lu LG
    J Dig Dis; 2009 Feb; 10(1):7-14. PubMed ID: 19236541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score?
    Tretheway D; Jain A; LaPoint R; Sharma R; Orloff M; Milot P; Bozorgzadeh A; Ryan C
    Liver Transpl; 2008 May; 14(5):695-700. PubMed ID: 18324621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver fibrosis in co-infected patients.
    Kelleher TB; Afdhal N
    J Hepatol; 2006; 44(1 Suppl):S126-31. PubMed ID: 16352364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of liver fibrosis in the clinical setting: something is changing?
    Berrutti M; Ciancio A; Smedile A; Brunello F; Bonardi R; Pellicano R; Astegiano M; Sapone N; Touscoz GA; Rizzetto M
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):111-4. PubMed ID: 17415348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G; Vario A; Guido M; Alberti A
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy?
    Mardini H; Record C
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):441-7. PubMed ID: 16259794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.
    Adams LA; Angulo P
    Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.